Hush Medical Spa
US$ 20.35
retatrutide clinical trial information Research Concentration Overview Lilly orforglipron oral GLP-1 phase
Description
You can, but I don't recommend it
The results demonstrated a dose-dependent effect on weight loss, with the maximum reduction reaching 14.7%, compared to only 2.3% in the placebo group
But Ive had patients who have had to stay on the lowest for 12 weeks and then go up and stay on the second dose for another 12 weeks. Alexis Mitchell, 30 of Charlotte, North Carolina, had been overweight for most of her 20s
2015 Oct;35(10):87381
